Visentin and colleagues demonstrated significantly reduced adiponectin levels in IUGR subjects, accompanied by elevated leptin, TNFα, and IL-6 levels (Visentin et al., 2014a; Visentin et al., 2014b; Visentin et al., 2013). This evidence concerns the gene ADIPOQ and fetal growth restriction.